340570

T&L is a South Korean specialty materials company that develops and manufactures high-functionality polymer-based products for medical and industrial applications. The company's core business involves the production of advanced wound dressings, including hydrocolloid, polyurethane foam, hydrogel, alginate, and silicone types, which are used to protect wounds, absorb exudate, and promote healing. T&L also manufactures orthopedic fixation devices such as casts and splints for fracture treatment and support. Leveraging its polymer technology, the company produces micro-needles for transdermal drug delivery and cosmetic applications, as well as semi-finished materials supplied to medical device and cosmetic manufacturers. Additionally, T&L develops chemical products such as water-based resins, curing agents, functional additives, and polyurethane foams for use in coatings, textiles, and synthetic leather. The company serves domestic hospitals, clinics, and pharmacies through a network of distributors and ODM partnerships with major pharmaceutical companies, while expanding its international presence through overseas agents and participation in global medical trade shows in the United States, Germany, China, and the Middle East. Founded in 1998, T&L operates an in-house research center focused on polymer engineering, biotechnology, and chemical engineering to drive product innovation.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Devices Homepage tnl.co.kr
Sector Healthcare IR page —
Tags
wound dressings, hydrocolloid, polyurethane foam, micro-needles, orthopedic fixation, transdermal drug delivery, polymer materials, medical devices, odm manufacturing, cosmetic ingredients, Illumiel, T&L Healthcare
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 20.4%
ROI 18.9%
ROIC 18.3%
Profit margin 23.2%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 21.7%
Quality  
Profitable Yes
Margin expanding No
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 164.158B 174.892B 115.461B 81.577B 71.896B 40.633B 32.623B 26.285B
Net profit 38.075B 46.408B 27.439B 21.118B 19.585B 10.042B 7.286B 4.658B
Free cash flow 20.105B 30.739B 19.139B -587.508M 3.372B 6.366B 3.972B 3.743B

Filed figures

Figure Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 4.57B 5.96B 7.08B 8.12B 13.3B 9.88B 16.3B 16.7B
↳ YoY growth +30.4% +18.8% +14.6% +63.4% -25.6% +64.8% +2.7%
↳ 5y CAGR +16.7% +22.2% +18.7%
Other receivables (KRW) — — — — — — — 18.1B
Borrowings, current (KRW) 995M 632M 0.00 0.00 0.00 0.00 0.00 0.00
Lease liabilities (KRW) 33.6M 19.8M 87.4M 249M 120M 112M 452M 318M
Cash and deposits (KRW) 2.77B 4.9B 14.6B 16.6B 20.6B 19.3B 60.7B 73.7B
Intangible assets (KRW) 1.24B 995M 1.37B 1.74B 1.71B 3.11B 3.64B 3.74B
Net debt (borrowings + leases - cash) (KRW) -1.74B -4.24B -14.5B -16.4B -20.5B -19.2B -60.3B -73.4B
Cash flow detail
Operating cash flow (KRW) 6.39B 7.83B 9.34B 19B 15.4B 32.6B 46.6B 37.7B
Purchases of property, plant and equipment (KRW) -2.65B -3.86B -2.98B -15.6B -16B -13.5B -15.8B -17.6B
Purchases of intangible assets (KRW) -163M -418M -461M -382M -10.4M -1.45B -581M -500M
Dividends paid (cash effect) (KRW) -960M -960M -1.28B -1.63B -3.25B -3.63B -4.44B -6.05B
Share buybacks (cash effect) (KRW) — — — 0.00 -1.88B -35,700 0.00 -3.27B
Interest paid (cash effect) (KRW) -134M -99.7M -30.1M -3.9M -33.5M -8.74M -19.6M -13.4M
Income taxes paid (cash effect) (KRW) -406M -623M -1.48B -1.39B -5.24B -4.59B -9.82B -15.1B
Free cash flow (OCF - PPE - intangibles) (KRW) 3.58B 3.55B 5.9B 2.99B -598M 17.7B 30.2B 19.6B
Income detail
Total comprehensive income (KRW) 4.44B 6.95B 10.1B 19.8B 21.1B 27.1B 46.3B 38.4B
Comprehensive income to owners (KRW) 4.44B 6.95B 10.1B 19.8B 21.1B 27.1B 46.3B 38.4B
Reported Mar 17, 2021 Mar 17, 2021 Mar 17, 2021 Mar 18, 2024 Mar 18, 2024 Mar 18, 2024 Mar 17, 2025 May 15, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

News

분기보고서 (2026.09) Bull 0 Bear 0 Routine
[기재정정]반기보고서 (2026.06) Bull 0 Bear 0 Routine
[첨부추가]반기보고서 (2026.06) Bull 0 Bear 0 Results

Prompts

T&L (ticker 340570), listed in South Korea.

ETFs Holding T&L

ETF Weight in ETF Shares Market value As of
DEXC 0.01% 1,054 $ 18.221K Nov 12, 2026
DFSE 0.01% 1,838 $ 31.774K Nov 12, 2026
DFEM 0.00% 17,173 $ 296.876K Nov 12, 2026
DFEV 0.00% 3,597 $ 62.183K Nov 12, 2026
DFAE 0.00% 9,572 $ 165.475K Nov 12, 2026
DFAX 0.00% 9,708 $ 167.826K Nov 12, 2026